114 related articles for article (PubMed ID: 30579865)
21. Acute myeloid leukemia with unreported translocation (x; 3) (q24; p13): A case report.
Gholami N; Khalaji A; Mehri M; Mehrtabar S; Habibzade E
Clin Case Rep; 2024 Feb; 12(2):e8543. PubMed ID: 38385056
[TBL] [Abstract][Full Text] [Related]
22. Identification of FOXP1 as a favorable prognostic biomarker and tumor suppressor in intrahepatic cholangiocarcinoma.
Tang C; Zhuang H; Tong H; Yu X; Chen J; Wang Q; Ma X; Wang B; Hua Y; Shang C; Tang Z
BMC Cancer; 2024 Jan; 24(1):137. PubMed ID: 38279090
[TBL] [Abstract][Full Text] [Related]
23. The Emerging Role of Tertiary Lymphoid Structures in Breast Cancer: A Narrative Review.
Narvaez D; Nadal J; Nervo A; Costanzo MV; Paletta C; Petracci FE; Rivero S; Ostinelli A; Freile B; Enrico D; Pombo MT; Amat M; Aguirre ED; Chacon M; Waisberg F
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254885
[TBL] [Abstract][Full Text] [Related]
24. PCMT1 knockdown attenuates malignant properties by globally regulating transcriptome profiles in triple-negative breast cancer cells.
Saiding A; Maimaitiyiming D; Chen M; Yan F; Chen D; Hu X; Shi P
PeerJ; 2023; 11():e16006. PubMed ID: 37953789
[TBL] [Abstract][Full Text] [Related]
25. Abrogating Metastatic Properties of Triple-Negative Breast Cancer Cells by EGFR and PI3K Dual Inhibitors.
Garcia AR; Mendes A; Custódia C; Faria CC; Barata JT; Malhó R; Figueira I; Brito MA
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568789
[TBL] [Abstract][Full Text] [Related]
26. miR-34a-FOXP1 Loop in Ovarian Cancer.
Dirimtekin E; Mortoglou M; Alavanda C; Benomar Yemlahi A; Arslan Ates E; Guney I; Uysal-Onganer P
ACS Omega; 2023 Aug; 8(30):27743-27750. PubMed ID: 37546627
[TBL] [Abstract][Full Text] [Related]
27. Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors.
Hayashi Y; Makino T; Sato E; Ohshima K; Nogi Y; Kanemura T; Honma K; Yamashita K; Saito T; Tanaka K; Yamamoto K; Takahashi T; Kurokawa Y; Miyata H; Nakajima K; Wada H; Morii E; Eguchi H; Doki Y
Br J Cancer; 2023 Jun; 128(12):2175-2185. PubMed ID: 37016103
[TBL] [Abstract][Full Text] [Related]
28. Regulation of T Cell Activation and Metabolism by Transforming Growth Factor-Beta.
Salmond RJ
Biology (Basel); 2023 Feb; 12(2):. PubMed ID: 36829573
[TBL] [Abstract][Full Text] [Related]
29. Neglected, yet significant role of FOXP1 in T-cell quiescence, differentiation and exhaustion.
Kaminskiy Y; Kuznetsova V; Kudriaeva A; Zmievskaya E; Bulatov E
Front Immunol; 2022; 13():971045. PubMed ID: 36268015
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide association study of actinic keratosis identifies new susceptibility loci implicated in pigmentation and immune regulation pathways.
Kim Y; Yin J; Huang H; Jorgenson E; Choquet H; Asgari MM
Commun Biol; 2022 Apr; 5(1):386. PubMed ID: 35449187
[TBL] [Abstract][Full Text] [Related]
31. Assessing deep learning methods in cis-regulatory motif finding based on genomic sequencing data.
Zhang S; Ma A; Zhao J; Xu D; Ma Q; Wang Y
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34607350
[TBL] [Abstract][Full Text] [Related]
32. Analysis of Bulk RNA Sequencing Data Reveals Novel Transcription Factors Associated With Immune Infiltration Among Multiple Cancers.
Liu L; Zhao Q; Cheng C; Yi J; Sun H; Wang Q; Quan W; Xue Y; Sun L; Cong X; Zhang Y
Front Immunol; 2021; 12():644350. PubMed ID: 34489925
[TBL] [Abstract][Full Text] [Related]
33. Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression.
Pellegrino B; Hlavata Z; Migali C; De Silva P; Aiello M; Willard-Gallo K; Musolino A; Solinas C
Mol Diagn Ther; 2021 Jul; 25(4):409-424. PubMed ID: 33974235
[TBL] [Abstract][Full Text] [Related]
34. Regulation of aromatase in cancer.
Molehin D; Rasha F; Rahman RL; Pruitt K
Mol Cell Biochem; 2021 Jun; 476(6):2449-2464. PubMed ID: 33599895
[TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation reveals differences in the tumor microenvironment.
Overkamp M; Granai M; Bonzheim I; Steinhilber J; Schittenhelm J; Bethge W; Quintanilla-Martinez L; Fend F; Federmann B
Virchows Arch; 2021 Jun; 478(6):1135-1148. PubMed ID: 33324999
[TBL] [Abstract][Full Text] [Related]
36. G9a regulates tumorigenicity and stemness through genome-wide DNA methylation reprogramming in non-small cell lung cancer.
Pangeni RP; Yang L; Zhang K; Wang J; Li W; Guo C; Yun X; Sun T; Wang J; Raz DJ
Clin Epigenetics; 2020 Jun; 12(1):88. PubMed ID: 32552834
[TBL] [Abstract][Full Text] [Related]
37. CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model.
Felce SL; Anderson AP; Maguire S; Gascoyne DM; Armstrong RN; Wong KK; Li D; Banham AH
Front Oncol; 2020; 10():448. PubMed ID: 32309216
[TBL] [Abstract][Full Text] [Related]
38. Systematic analyses of genetic variants in chromatin interaction regions identified four novel lung cancer susceptibility loci.
Ji P; Ding D; Qin N; Wang C; Zhu M; Li Y; Dai J; Jin G; Hu Z; Shen H; Chen L; Ma H
J Cancer; 2020; 11(5):1075-1081. PubMed ID: 31956354
[TBL] [Abstract][Full Text] [Related]
39. CXCL9 chemokine promotes the progression of human pancreatic adenocarcinoma through STAT3-dependent cytotoxic T lymphocyte suppression.
Gao HF; Cheng CS; Tang J; Li Y; Chen H; Meng ZQ; Chen Z; Chen LY
Aging (Albany NY); 2020 Jan; 12(1):502-517. PubMed ID: 31913856
[TBL] [Abstract][Full Text] [Related]
40. Molecular networks of FOXP family: dual biologic functions, interplay with other molecules and clinical implications in cancer progression.
Kim JH; Hwang J; Jung JH; Lee HJ; Lee DY; Kim SH
Mol Cancer; 2019 Dec; 18(1):180. PubMed ID: 31815635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
